Results

Total Results: over 10,000 records

Showing results for "indicator".
Users also searched for: quality indicators

  1. www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-148-testing-summary.pdf
    June 02, 2025 - Measures To Assess the Safe and Judicious Use of Antipsychotics in Children and Adolescents Field Test Summary 1 National Collaborative for Innovation in Quality Measurement (NCINQ) Measures to Assess the Safe and Judicious Use of Antipsychotics in Children and Adolescents Field Test Summary This report sum…
  2. www.ahrq.gov/patient-safety/settings/long-term-care/resource/hcbs/report/apv2a.html
    June 01, 2010 - Environmental Scan of Measures for Medicaid Title XIX Home and Community-Based Services Appendix V: Tested Measures by DRA Domain (continued) Previous Page Next Page Table of Contents Environmental Scan of Measures for Medicaid Title XIX Home and Community-Based Services Executive Summary Introd…
  3. psnet.ahrq.gov/issue/comparing-safety-performance-and-user-perceptions-patient-specific-indication-based
    December 18, 2019 - Study Comparing safety, performance and user perceptions of a patient-specific indication-based prescribing tool with current practice: a mixed methods randomised user testing study. Citation Text: Feather C, Clarke J, Appelbaum N, et al. Comparing safety, performance and user perception…
  4. www.ahrq.gov/sites/default/files/wysiwyg/antibiotic-use/improve/team-antibiotic-review-form.docx
    November 01, 2019 - AHRQ Safety Program for Improving Antibiotic Use Team Antibiotic Review Form *Questions 1–6 should be answered for all patients you evaluate who are actively receiving antibiotics. Question 1: Day of antibiotic therapy (choose one) ☐Day 1 ☐Day 2 ☐Day 3 ☐Day 4 ☐Day 5 ☐Day 6 ☐> 7 Days Question 2: Record antibi…
  5. digital.ahrq.gov/sites/default/files/docs/citation/r01hs024945-lambert-final-report-2022.pdf
    January 01, 2022 - Preventing Wrong-Drug and Wrong-Patient Errors with Indication Alerts in CPOE Systems – Final Report 1 Final Progress Report Preventing Wrong-Drug and Wrong-Patient Errors with Indication Alerts in CPOE Systems R01HS024945 Agency for Healthcare Research and Quality September 30, 2016 — September 29, 20…
  6. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/43227/psn-pdf
    June 04, 2014 - Detecting adverse events in surgery: comparing events detected by the Veterans Health Administration Surgical Quality Improvement Program and the Patient Safety Indicators. June 4, 2014 Mull HJ, Borzecki A, Loveland S, et al. Detecting adverse events in surgery: comparing events detected by the Veterans Health Ad…
  7. www.ahrq.gov/patient-safety/settings/long-term-care/resource/hcbs/report/rep3.html
    June 01, 2010 - xiii Others are specific to populations and settings, such as the Home-Based Primary Care Quality Indicator
  8. www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/quality-resources/tools/cauti-ltc/modules/implementation/long-term-modules/module6/module-6-slides.pptx
    March 01, 2017 - Consider measuring how frequently senior leaders/administrators review sustainability data/outcomes as indicator
  9. www.ahrq.gov/hai/quality/tools/cauti-ltc/modules/implementation/long-term-modules/module6/mod6-slides.html
    March 01, 2017 - Consider measuring how frequently senior leaders/administrators review sustainability data/outcomes as indicator
  10. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/33781/psn-pdf
    March 01, 2015 - hospitals with high adjusted death rates (9 on the HSMR and 5 on the Standardized Hospital Mortality Indicator
  11. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/33868/psn-pdf
    October 01, 2018 - www.ncbi.nlm.nih.gov/pubmed/16299427 https://psnet.ahrq.gov//#ref6back https://www.kff.org/health-costs/state-indicator
  12. www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/chipra_15-p001-1-ef.pdf
    January 01, 2015 - ● These measures can serve as a potential indicator of quality and access and reflect performance
  13. www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/duration/chipra-153-section-8a.pdf
    January 01, 2011 - considered to be “enrolled” for the whole month if they have evidence of S-CHIP enrollment via a monthly indicator
  14. www.ahrq.gov/prevention/resources/chronic-care/ccrm-atlas-suppl/ccrm-atlas3-6.html
    October 01, 2013 - measure may be adapted from the Canadian Institute for Health Information: Self-management support indicator
  15. www.ahrq.gov/sites/default/files/wysiwyg/hai/tools/clabsi-cauti-icu/central-catheter-indications.pptx
    April 01, 2022 - Central Venous Catheter Indications and Alternatives: Avoiding Placement and Determining Appropriateness Central Venous Catheter Indications and Alternatives Avoiding Placement and Determining Appropriateness AHRQ Safety Program for Intensive Care Units: Preventing CLABSI and CAUTI AHRQ Pub. No. 17(22)-0019 April 2022…
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-drugs-utilization_research.pdf
    January 01, 2011 - Utilization of anticancer biologic products among Medicare beneficiaries, by diagnostic cancer subchapter, 2006-2009 Anticancer Biologics Data Points #7 Fewer than 50 percent of beneficiaries with bevacizumab orders had a cancer diagnosis in the prior 6 months. This was driven by the biologic’s off-label use …
  17. effectivehealthcare.ahrq.gov/sites/default/files/comparator-selection-in-observational-chapter-5.pptx
    January 01, 2013 - Slide 1 Comparator Selection in Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare Research and Quality (AHRQ) www.ahrq.gov Comparator Selection in Observational Comparative Effectiveness Research This slide set is based on a user guide titled Developing a Protocol for Observation…
  18. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/recombinant-factor-viia_executive.pdf
    May 01, 2010 - Layout 1 Background This report evaluates the level of evidence currently available to support the effectiveness and safety of using recombinant activated coagulation factor VII (rFVIIa) for clinical indications not approved by the U. S. Food and Drug Administration (FDA). rFVIIa is approved for a variety of uses i…
  19. www.ahrq.gov/sites/default/files/wysiwyg/nhguide/TK3_T5_Minimum_Criteria_Nursing_Staff_Training.docx
    October 01, 2016 - or smelly urine and other symptoms not mentioned in the Suspected UTI SBAR form were considered an indicator
  20. www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/qitoolkit/combined/d4y_combo_nqi03-bsi-bestpractices.pdf
    May 17, 2016 - Hospital-Acquired Conditions (Present on Admission Indicator). http://www.cms.gov/Medicare/Medicare-Fee-for-Service